VTRS FY 2013 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$6.9B+1.7% YoY

Gross Profit

$3.0B44.0% margin

Operating Income

$1.1B16.4% margin

Net Income

$624M9.0% margin

EPS (Diluted)

$1.58

Cash Flow

Operating Cash Flow

$1.1B

Free Cash Flow

$772M

Stock-Based Comp.

$47M

Balance Sheet

Total Assets

$15.3B

Total Liabilities

$12.3B

Stockholders' Equity

$2.9B

Cash & Equivalents

$291M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6.9B	$6.8B	+1.7%
Gross Profit	$3.0B	$2.9B	+4.5%
Operating Income	$1.1B	$1.1B	+2.4%
Net Income	$624M	$641M	-2.7%